Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Question About The Other Plan
1
Sep 05, 2014 03:01PM

You are missing something. First of all, the Alliacense agreement with PDS remains in place. They have an ironclad agreement that only Alliacense can walk away from. Check the Debtor's 1st disclosure statement on the subject. If you have any Leckrone entity managing any aspect of the portfolio, you have Leckrone running the show, IMO. Alliacense is wholly owned by Leckrone.

Share
New Message
Please login to post a reply